Literature DB >> 15809278

Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors.

Frank M Raaphorst1.   

Abstract

Genes belonging to the Polycomb-group (PcG) are epigenetic gene silencers with a vital role in the maintenance of cell identity. They contribute to regulation of various processes in both embryos and adults, including the cell cycle and lymphopoiesis. A growing body of work has linked human PcG genes to various hematological and epithelial cancers, identifying novel mechanisms of malignant transformation and paving the way to development of new cancer treatments and identification of novel diagnostic markers. This review addresses the current insights in the role of PcG genes in development of human malignancies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809278     DOI: 10.1093/hmg/ddi111

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  47 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers.

Authors:  Edward Y Chen; Huilei Xu; Simon Gordonov; Maribel P Lim; Matthew H Perkins; Avi Ma'ayan
Journal:  Bioinformatics       Date:  2011-11-10       Impact factor: 6.937

3.  Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets.

Authors:  Micah D Gearhart; Connie M Corcoran; Joseph A Wamstad; Vivian J Bardwell
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 4.  Genomic alterations in Hodgkin's lymphoma.

Authors:  Marc A Weniger; Thomas F E Barth; Peter Möller
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

5.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

Authors:  Adrian P Bracken; Nikolaj Dietrich; Diego Pasini; Klaus H Hansen; Kristian Helin
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

6.  Suz12 binds to silenced regions of the genome in a cell-type-specific manner.

Authors:  Sharon L Squazzo; Henriette O'Geen; Vitalina M Komashko; Sheryl R Krig; Victor X Jin; Sung-wook Jang; Raphael Margueron; Danny Reinberg; Roland Green; Peggy J Farnham
Journal:  Genome Res       Date:  2006-06-02       Impact factor: 9.043

7.  Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.

Authors:  Bin Shi; Jing Liang; Xiaohan Yang; Yan Wang; Youna Zhao; Huijian Wu; Luyang Sun; Ying Zhang; Yupeng Chen; Ruifang Li; Yu Zhang; Mei Hong; Yongfeng Shang
Journal:  Mol Cell Biol       Date:  2007-05-14       Impact factor: 4.272

8.  Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.

Authors:  Lynda B Bennett; Kristen H Taylor; Gerald L Arthur; Farahnaz B Rahmatpanah; Sam I Hooshmand; Charles W Caldwell
Journal:  Epigenomics       Date:  2010-02-01       Impact factor: 4.778

9.  The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.

Authors:  Sivaprakasam Balasubramanian; Gautam Adhikary; Richard L Eckert
Journal:  Carcinogenesis       Date:  2009-12-16       Impact factor: 4.944

10.  Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.

Authors:  Stella Tommasi; Deborah L Karm; Xiwei Wu; Yun Yen; Gerd P Pfeifer
Journal:  Breast Cancer Res       Date:  2009-02-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.